NCT00237016View on ClinicalTrials.gov

Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

April 30, 2003

Conditions
Relapsing Fever, Tick-borneJarisch Herxheimer Reaction
Interventions
DRUG

doxycycline treatment

Trial Locations (1)

Unknown

Israel Defence Forces, Tel Litwinsky

All Listed Sponsors
lead

Medical Corps, Israel Defense Force

OTHER

NCT00237016 - Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever | Biotech Hunter | Biotech Hunter